Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:491-496

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giannattasio, C.
Right arrow Articles by Mancia, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giannattasio, C.
Right arrow Articles by Mancia, G.

(Hypertension. 1995;26:491-496.)
© 1995 American Heart Association, Inc.


Articles

Angiotensin-Converting Enzyme Inhibition and Radial Artery Compliance in Patients With Congestive Heart Failure

Cristina Giannattasio; Monica Failla; Maria L. Stella; Arduino A. Mangoni; Davide Turrini; Stefano Carugo; Massimo Pozzi; Guido Grassi; Giuseppe Mancia

From Cattedra di Medicina Interna, Università di Milano and Ospedale S. Gerardo di Monza; Centro Auxologico Italiano, Milano; and Centro di Fisiologia Clinica e Ipertensione, Ospedale Maggiore, Milano, Italy.

Abstract Congestive heart failure is characterized by a clear-cut impairment of arterial compliance of medium-sized arteries, but whether this alteration is irreversible or can be favorably affected by cardiovascular drugs currently used in congestive heart failure treatment is unknown. We studied 9 congestive heart failure patients (New York Heart Association class II; age, [mean±SEM] 60.7±3.3 years) receiving diuretic and digitalis treatment in whom arterial compliance was assessed at the level of the radial artery by an echotracking device capable of measuring the arterial diameter along the entire cardiac cycle. Beat-to-beat arterial blood pressure was concomitantly measured by a Finapres device that allowed diameter-pressure curves and compliance-pressure curves (Langewouters' formula) to be calculated for the entire systolic-diastolic blood pressure range. Arterial compliance was expressed as the area under the compliance-pressure curve normalized for pulse pressure (compliance index). Data were collected before and after 4 and 8 weeks of oral administration of benazepril (10 mg/day). Ten healthy subjects were studied before and after an observational period of 4 weeks (5 subjects) or 8 weeks (5 subjects), and 9 age-matched mildly essential hypertensive subjects studied before and after 4 to 12 weeks of benazepril administration served as control subjects. In congestive heart failure patients, baseline compliance index was significantly less than in normotensive and hypertensive subjects. However, the compliance index showed a marked increase after 4 weeks of benazepril administration (+95.7±24.9%, P<.05); the increase was also marked after 8 weeks of angiotensin-converting enzyme inhibitor treatment (+77.7±4.2%, P<.05). At this time the compliance values of the congestive heart failure patients were not different from those of the healthy and hypertensive groups, in which the observational period and angiotensin-converting enzyme inhibitor administration, respectively, had brought no change in compliance. Similar results were observed when compliance index was calculated for the blood pressure range shared by the three groups (isobaric compliance). These data provide the first evidence that the impairment of arterial compliance occurring in congestive heart failure can be favorably affected by the addition of an angiotensin-converting enzyme inhibitor to the treatment regimen. This has favorable implications for the cardiovascular functions adversely affected by a reduced arterial compliance (eg, cardiac work and oxygen consumption, coronary perfusion, and arterial baroreflex).


Key Words: arteries • heart failure, congestive • circulation • angiotensin-converting enzyme inhibitors




This article has been cited by other articles:


Home page
Eur Heart JHome page
S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, B. Pannier, C. Vlachopoulos, I. Wilkinson, H. Struijker-Boudier, et al.
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Eur. Heart J., November 1, 2006; 27(21): 2588 - 2605.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Ahimastos, A. K. Natoli, A. Lawler, P. A. Blombery, and B. A. Kingwell
Ramipril Reduces Large-Artery Stiffness in Peripheral Arterial Disease and Promotes Elastogenic Remodeling in Cell Culture
Hypertension, June 1, 2005; 45(6): 1194 - 1199.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
C. Giannattasio, F. Achilli, M. Failla, A. Capra, A. Vincenzi, G. Gentile, D. Corsi, C. Zazzeron, L. Turolo, A. Morganti, et al.
Arterial stiffness in heart failure patients: dependance on diastolic dysfunction and plasma aldosterone levels
Eur. Heart J. Suppl., November 1, 2004; 6(suppl_F): F30 - F34.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. G. Lage, L. Kopel, C. C. J. Medeiros, R. T. Carvalho, and M. A. Creager
Angiotensin II contributes to arterial compliance in congestive heart failure
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1424 - H1429.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Giannattasio, F. Achilli, M. Failla, A. Capra, A. Vincenzi, F. Valagussa, and G. Mancia
Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade
J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1275 - 1282.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. R. Kaiser, K. Mullen, and A. J. Bank
Brachial Artery Elastic Mechanics in Patients With Heart Failure
Hypertension, December 1, 2001; 38(6): 1440 - 1445.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Joannides, C. Bizet-Nafeh, A. Costentin, M. Iacob, G. Derumeaux, A. Cribier, and C. Thuillez
Chronic ACE Inhibition Enhances the Endothelial Control of Arterial Mechanics and Flow-Dependent Vasodilatation in Heart Failure
Hypertension, December 1, 2001; 38(6): 1446 - 1450.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Giannattasio, M. Failla, A. Grappiolo, M. Bigoni, S. Carugo, M. Denti, and G. Mancia
Effects of Prolonged Immobilization of the Limb on Radial Artery Mechanical Properties
Hypertension, September 1, 1998; 32(3): 584 - 587.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Mangoni, L. Mircoli, C. Giannattasio, G. Mancia, and A. U. Ferrari
Effect of Sympathectomy on Mechanical Properties of Common Carotid and Femoral Arteries
Hypertension, November 1, 1997; 30(5): 1085 - 1088.
[Abstract] [Full Text]


Home page
CirculationHome page
G. Grassi, B. M. Cattaneo, G. Seravalle, A. Lanfranchi, M. Pozzi, A. Morganti, S. Carugo, and G. Mancia
Effects of Chronic ACE Inhibition on Sympathetic Nerve Traffic and Baroreflex Control of Circulation in Heart Failure
Circulation, August 19, 1997; 96(4): 1173 - 1179.
[Abstract] [Full Text]


Home page
HypertensionHome page
C. Giannattasio, A. A. Mangoni, M. Failla, M. L. Stella, S. Carugo, M. Bombelli, R. Sega, and G. Mancia
Combined Effects of Hypertension and Hypercholesterolemia on Radial Artery Function
Hypertension, February 1, 1997; 29(2): 583 - 586.
[Abstract] [Full Text]